Global External Beam Radiation Therapy (EBRT) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

External Beam Radiation Therapy (EBRT) Market Size

• The global external beam radiation therapy (EBRT) market size was valued at USD 13.5 billion in 2025and is expected to reach USD 24.08 billion by 2033, at a CAGR of 7.5% during the forecast period
• The market growth is primarily driven by the rising global burden of cancer, increasing adoption of advanced radiation oncology technologies, and growing demand for precise, non-invasive cancer treatment modalities
• In addition, continuous technological advancements in radiation delivery systems, improved treatment accuracy, and expanding access to oncology care in emerging economies are significantly contributing to the market expansion

External Beam Radiation Therapy (EBRT) Market Analysis

• External Beam Radiation Therapy (EBRT) is a cornerstone of modern cancer treatment, utilizing high-energy radiation beams directed externally at tumor sites to destroy cancer cells while minimizing damage to surrounding healthy tissue. It is widely used across hospitals and specialized oncology centers for both curative and palliative cancer management
• The increasing incidence of cancer globally, particularly lung, breast, and prostate cancers, is a major factor driving the demand for EBRT systems. Aging populations, lifestyle changes, and environmental risk factors are further contributing to rising cancer prevalence
• North America dominated the global external beam radiation therapy (EBRT) market accounting for the largest revenue share of 41.9% in 2025, supported by advanced healthcare infrastructure, early adoption of cutting-edge radiation technologies, and a strong presence of major oncology solution providers
• Asia-Pacific is expected to witness the fastest growth in the global external beam radiation therapy (EBRT) market during the forecast period due to rapidly increasing cancer cases, improving healthcare infrastructure, and rising investments in oncology care facilities across countries such as China and India
• Linear Accelerators (LINAC) dominated the global external beam radiation therapy (EBRT) market due to their widespread clinical adoption, high precision in dose delivery, and ability to treat complex tumor geometries

Report Scope and External Beam Radiation Therapy (EBRT) Market Segmentation

External Beam Radiation Therapy (EBRT) Market Trends

“Shift Toward Precision, Image-Guided, and AI-Integrated Radiation”

• A major trend in the EBRT market is the transition toward highly precise, image-guided, and adaptive radiation therapy systems that improve tumor targeting while reducing exposure to healthy tissues.
• For instance, advanced IGRT and VMAT systems are increasingly being adopted in oncology centers to enable real-time imaging and dynamic beam modulation during treatment.
• The integration of AI-based treatment planning tools is enhancing dose optimization, reducing planning time, and improving clinical decision-making.
• Proton beam therapy is gaining traction for pediatric and complex cancer cases due to its superior dose distribution and reduced long-term side effects.
• The increasing use of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT) is enabling high-dose, short-duration treatments for localized tumors with improved patient convenience.
• Growing emphasis on personalized cancer treatment is reshaping radiation oncology practices toward more adaptive and patient-specific therapy protocols.

External Beam Radiation Therapy (EBRT) Market Dynamics

Driver

“Rising Global Cancer Burden and Advancements in Radiation Oncology”

• The increasing prevalence of cancer worldwide is the primary driver of EBRT market growth, with lung, breast, and prostate cancers accounting for a significant proportion of radiation therapy demand.
• Continuous advancements in radiation delivery systems, including LINAC upgrades and image-guided technologies, are improving treatment precision and clinical outcomes.
• Expanding healthcare infrastructure in emerging economies is increasing access to radiation therapy services.
• Growing preference for non-invasive and organ-preserving cancer treatments is further supporting EBRT adoption across healthcare settings.
• Increasing awareness about early cancer diagnosis and treatment is contributing to higher utilization of radiation therapy in standard oncology care pathways.

Restraint/Challenge

“High Equipment Costs and Limited Access in Low-Resource Settings”

• The high cost of advanced radiation therapy systems, such as proton therapy and robotic radiosurgery platforms, limits adoption in low- and middle-income regions.
• Installation and maintenance of EBRT systems require significant infrastructure, shielding, and skilled personnel, creating operational challenges for smaller healthcare facilities.
• Shortage of trained radiation oncologists and medical physicists in several regions restricts optimal utilization of available technologies.
• Complex regulatory approvals and long deployment timelines for advanced systems can delay market entry for new technologies.
• Unequal access to cancer care infrastructure continues to be a key barrier in achieving global treatment equity.

External Beam Radiation Therapy (EBRT) Market Scope

The market is segmented based on technology, treatment type, application, and end user.

• By Technology

On the basis of technology, the global External Beam Radiation Therapy (EBRT) market is segmented into Linear Accelerators (LINAC), IMRT, IGRT, SRS/SBRT, VMAT, 3D-CRT, Proton Beam Therapy/Particle Therapy, and Tomotherapy systems. The Linear Accelerators (LINAC) segment dominated the market in 2025 due to its widespread use as the standard platform for delivering radiation therapy across multiple cancer types. LINAC systems are widely preferred for their versatility, precision, and compatibility with advanced techniques such as IMRT and IGRT, making them the backbone of most radiation oncology departments.

The Proton Beam Therapy/Particle Therapy segment is expected to witness the fastest growth during the forecast period due to increasing demand for highly precise cancer treatment with reduced damage to surrounding healthy tissues. Rising investments in proton therapy centers and growing use in complex and pediatric cancers are supporting adoption, despite high installation and operational costs.

• By Application

On the basis of application, the global External Beam Radiation Therapy (EBRT) market is segmented into lung cancer, breast cancer, prostate cancer, colorectal cancer, head & neck cancer, brain tumors, cervical cancer, and others. Lung cancer dominates the market in 2025 due to its high global prevalence and strong reliance on radiation therapy for both curative and palliative treatment. EBRT is widely used either alone or in combination with chemotherapy for lung cancer management.

Brain tumors are expected to witness the fastest growth due to increasing adoption of advanced techniques such as stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). These technologies enable highly precise tumor targeting with minimal impact on healthy brain tissue, improving treatment outcomes.

• By End User

On the basis of end user, the global External Beam Radiation Therapy (EBRT) market is segmented into hospitals, oncology centers, ambulatory radiotherapy centers, and academic & research institutes. Hospitals dominate the market in 2025 due to high patient inflow, availability of advanced radiation therapy systems, and integrated oncology care infrastructure. They serve as the primary point of diagnosis and treatment for most cancer patients.

Ambulatory radiotherapy centers are expected to witness the fastest growth during the forecast period due to rising demand for outpatient cancer care and cost-effective treatment delivery models. Increasing availability of compact radiation systems and growing patient preference for convenient treatment settings are supporting this shift.

External Beam Radiation Therapy (EBRT) Market Regional Analysis

• North America dominated the External Beam Radiation Therapy (EBRT) market, driven by advanced oncology infrastructure, early adoption of cutting-edge radiation technologies, and strong presence of key market players. The region accounted for the largest market share of 41.9% in 2025, supported by well-established cancer care systems and high treatment adoption rates.
• The region benefits from strong reimbursement frameworks and high healthcare expenditure, which enable widespread access to advanced radiation therapy systems such as LINAC, IMRT, and proton therapy across hospitals and oncology centers.
• Increasing cancer prevalence, along with strong awareness of early diagnosis and routine screening programs, is further driving demand for External Beam Radiation Therapy across both curative and palliative treatment settings in North America.

U.S. External Beam Radiation Therapy (EBRT) Market Insight

The U.S. External Beam Radiation Therapy (EBRT) market is the largest contributor within North America, driven by a high prevalence of cancer cases, strong access to advanced oncology infrastructure, and early adoption of innovative radiation technologies such as IMRT, IGRT, and proton therapy. Widespread availability of reimbursement support, along with increasing use of precision and image-guided radiation systems, is further boosting market growth. In addition, the growing shift toward outpatient cancer care and integration of AI-based treatment planning tools is enhancing treatment efficiency and strengthening the adoption of EBRT across healthcare facilities.

Europe External Beam Radiation Therapy (EBRT) Market Insight

The Europe External Beam Radiation Therapy (EBRT) market is witnessing steady growth, driven by the rising incidence of cancer, increasing aging population, and strong emphasis on early diagnosis and standardized oncology care pathways. The region benefits from well-established healthcare systems, favorable reimbursement policies, and growing adoption of advanced radiation technologies such as IMRT, IGRT, and VMAT across hospitals and cancer centers. In addition, increasing investments in modernizing radiotherapy infrastructure and expanding access to precision cancer treatment are further supporting market expansion across major European countries.

U.K. External Beam Radiation Therapy (EBRT) Market Insight

The U.K. External Beam Radiation Therapy (EBRT) market is growing steadily, supported by strong national healthcare programs for cancer care, increasing prevalence of lung, breast, and prostate cancers, and widespread access to advanced radiotherapy services under the National Health Service (NHS). The country is witnessing rising adoption of precision radiation technologies such as IMRT, IGRT, and stereotactic radiotherapy, aimed at improving treatment outcomes and reducing side effects. In addition, growing focus on early diagnosis, expansion of specialized cancer centers, and increasing awareness of modern radiation treatment options are further driving market growth in the U.K.

Germany External Beam Radiation Therapy (EBRT) Market Insight

The Germany External Beam Radiation Therapy (EBRT) market is experiencing steady growth, supported by a strong healthcare system, high adoption of advanced medical technologies, and increasing focus on precision oncology. The country’s well-established network of cancer treatment centers is driving widespread use of advanced radiation techniques such as IMRT, IGRT, and VMAT to improve treatment accuracy and patient outcomes. In addition, rising cancer incidence, strong emphasis on early diagnosis, and continuous investments in upgrading radiotherapy infrastructure are further contributing to market expansion in Germany.

Asia-Pacific External Beam Radiation Therapy (EBRT) Market Insight

The Asia-Pacific External Beam Radiation Therapy (EBRT) market is witnessing rapid growth, driven by the rising burden of cancer, increasing healthcare expenditure, and improving access to advanced oncology care across emerging economies. Countries such as China, India, and Japan are expanding their radiotherapy infrastructure, supported by government initiatives and growing investments in cancer treatment facilities. In addition, increasing adoption of advanced technologies such as IMRT, IGRT, and LINAC systems, along with rising awareness of early cancer diagnosis, is significantly boosting demand for EBRT in the region.

Japan External Beam Radiation Therapy (EBRT) Market Insight

The Japan External Beam Radiation Therapy (EBRT) market is steadily growing, supported by the country’s aging population, high cancer prevalence, and strong emphasis on advanced medical technologies. Japan has a well-developed healthcare infrastructure with widespread adoption of precision radiation techniques such as IMRT, IGRT, and stereotactic radiotherapy to improve treatment accuracy and patient outcomes. In addition, increasing use of compact and highly automated radiation systems, along with strong integration of innovation in oncology care, is further driving the adoption of EBRT across hospitals and specialized cancer treatment centers in the country.

India External Beam Radiation Therapy (EBRT) Market Insight

The India External Beam Radiation Therapy (EBRT) market is witnessing strong growth, driven by the rising burden of cancer, rapid urbanization, and increasing exposure to risk factors such as air pollution and lifestyle changes. Expanding healthcare infrastructure, along with improving access to advanced oncology treatments in both public and private sectors, is supporting the adoption of EBRT systems across the country. In addition, growing investments in cancer care facilities, rising awareness about early diagnosis, and increasing availability of cost-effective radiation therapy solutions from domestic manufacturers are further accelerating market growth in India.

External Beam Radiation Therapy (EBRT) Market Share

The external beam radiation therapy (EBRT) industry is primarily led by well-established companies, including:

• Varian Medical Systems (U.S.)
• Elekta AB (Sweden)
• Siemens Healthineers AG (Germany)
• Accuray Incorporated (U.S.)
• Mevion Medical Systems (U.S.)
• Hitachi Ltd. (Japan)
• Canon Inc. (Japan)
• Brainlab AG (Germany)
• ViewRay Technologies (U.S.)
• Sumitomo Heavy Industries (Japan)
• United Imaging Healthcare (China)
• Mitsubishi Electric (Japan)
• Panacea Medical Technologies (India)
• Best Theratronics (Canada)

What are the Recent Developments in Global External Beam Radiation Therapy (EBRT) Market?

• In October 2025, Siemens Healthineers (Varian) showcased next-generation radiation oncology innovations at ASTRO 2025, including the Halcyon platform upgrades and HyperSight imaging technology, designed to improve treatment precision, workflow efficiency, and patient comfort in EBRT delivery systems
• In September 2025, Siemens Healthineers introduced photon-counting CT (Naeotom Alpha.Prime) for radiation therapy planning, enabling higher-resolution imaging and improved tumor targeting accuracy for EBRT treatment planning workflows
• In September 2025, Accuray launched its Accuray Stellar adaptive radiotherapy solution, enhancing real-time treatment adaptation and enabling more personalized EBRT delivery across complex cancer cases
• In May 2025, Accuray presented long-term clinical data at ESTRO 2025 highlighting improved outcomes using CyberKnife SBRT technology for prostate cancer, reinforcing the growing clinical adoption of stereotactic EBRT techniques

SKU-76087